US Recall News

United States Recall News Alerts for Recalled Drugs, Food, Products, & Vehicles

MENUMENU
  • Home
  • About
    • Advertise
  • Full Recall News Archive
    • Top Story

      J&J Settles Talc Mesothelioma Settlement

      By Sandra Dalton, Staff Writer On January 6, 2020, Superior Court Judge Stephen Kaus announced that Johnson & Johnsons (J&J) had agreed to … [Read More...]

      Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits

      Summary Company Announcement Date: January 30, 2023 FDA Publish Date: … [Read More...]

    • More Safety Articles
    • Federal Preemption of State Product Liability Law
  • Drug Recalls
    • Abilify
    • Benicar
    • Fluoroquinolones
    • Invokana
    • Lipitor
    • Nuplazid
    • Opioids
    • OxyContin
    • Pradaxa
    • Proton Pump Inhibitors (PPIs)
    • Risperdal
    • SSRI
    • Symptoms & Side Effects
    • Taxotere
    • Testosterone
    • Uloric
    • Valsartan
    • Xarelto
    • Zofran
  • Medical Devices
    • 3M Earplug
    • 3T Heater-Cooler System
    • Bair Hugger
    • Bipolar Hip System
    • Essure
    • Hip Replacements
    • Implanon
    • IVC Filters
    • Hernia Mesh
    • Power Morcellators
    • Shoulder Implants
    • Transvaginal Mesh
  • Food Recalls
    • FDA Press Releases
    • USDA Press Releases
  • Auto Recalls
    • Air Bags
    • Ignitions
    • NHTSA Press Releases
    • Off-Road Utility Vehicles
    • Snowmobiles
    • Tires
  • Other Products
    • Asbestos
    • Baby Products
    • Pet Products
    • Roundup
    • Talcum Powder
    • Toy Recalls
You are here: Home / Drug Recalls / FDA Issues Warning about More Depakote Birth Defect Risk

FDA Issues Warning about More Depakote Birth Defect Risk

May 15, 2013 By Candelaria Leave a Comment

After a new study linked Depakote and other valproate medications taken during pregnancy to an increased risk of autism and autism spectrum disorders, the FDA has decided to put its strongest warning for pregnancy associated complications on the drug, designating it pregnancy class X for migraine prevention, which means that the drug’s dangers outweigh its benefits for pregnant women. The new study adds to other work showing the drug increases risk for birth defects when taken by pregnant women.

What Is Depakote?

Depakote is a commercial name for a valproate product, specifically divalproex sodium. It comes in three different variations, including Depakote CP and Depakote ER. Other variations on the drug include:

  • Valproate sodium (Depacon, an injectable formulation)
  • Valproic acid (Depakene and Stavzor)

As well as generic formulations.

Valproate products are approved for migraine prevention, epilepsy, and bipolar disorder.

Study Shows Depakote Increases Risk of Autism

A study published in the Journal of the American Medical Association in April showed that women who took Depakote or similar drugs during pregnancy were more likely to give birth to children with autism or autism spectrum disorders. The study looked at birth and pediatric records for children in the Danish health registry from 1996 to 2006. The study compared children of women given Depakote during pregnancy with women who did not take the drug during pregnancy and found the drug was associated with:

  • A 3X increase in risk for autism spectrum disorders (1.53% vs. 4.44%)
  • A 5X increase in risk for childhood autism (0.48% vs. 2.56%)

In an attempt to remove a potential confounder, the study also compared children born to mothers with epilepsy and found that even in this limited group Depakote was associated with elevated risk of:

  • 1.7X increase in risk for autism spectrum disorders (2.44% vs. 4.15%)
  • 3X increase in risk for childhood autism (1.02% vs. 2.95%)

The current study is a follow-up of work previously reported in 2011, about which the FDA had also issued a warning.

Autism spectrum disorder is a broad class of conditions that includes autism, Asperger syndrome, Rett syndrome, and others.

Depakote Already Associated with Birth Defects

The troubled drug Depakote has already been associated with birth defect risks. A 2010 review of studies linked the drug to an increased risk of birth defects when taken by mothers in their first trimester. The risks increased significantly for six different types of birth defects:

  • Spina bifida (12.7X increased risk)—in which the neural tube fails to close around the brain and spinal cord
  • Craniosynostosis (6.8X)—in which one or more of the cranial sutures on the baby’s skull closes prematurely
  • Cleft palate (5.2X)
  • Hypospadias (4.8X)—in which the urethra opening in the penis is in the bottom rather than the end
  • Atrial septal defect (2.5X)
  • Polydactyly (2.2X)

Although the study noted that the risks for Depakote were similar to those for other antiepileptic drugs, which probably contributed to the FDA’s decision to continue to allow the drug for pregnant women, although a black box warning describing the risks was added in 2009.

FDA Action

However, since the current research seems to indicate that the risks for Depakote and similar drugs outweigh the benefits for migraine prevention, the FDA has decided it is time to change the classification of the drug, from the current pregnancy class D (positive evidence of human fetal risk) to pregnancy class X (risks of use clearly outweigh benefits).

The drug will remain in pregnancy class D for control of manic episodes and epilepsy.

The change will not take place immediately, since new labeling must be written, but all patients and doctors should be aware of the new classification and consider alternate treatment for migraine prevention in pregnant women. Women of childbearing age are encouraged to use effective birth control if they are taking Depakote or other types of valproic acid.

There are already numerous lawsuits in progress for birth defects associated with valproic acid. It is likely that more will be filed after this labeling change.

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • Print

Related

Filed Under: Drug Recalls, Featured, Symptoms & Side Effects, Urgent Recalls

About Candelaria

Leave a Reply Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Facebook
Thomas Roney LLC
Economic Consulting

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits

January 30, 2023 By The FDA

Sovos Brands Intermediate, Inc. Issues Allergy Alert on Undeclared Egg in Rao’s Slow Simmered Soup, Labeled as Chicken & Gnocchi but Containing Vegetable Minestrone

January 27, 2023 By The FDA

Edgewell Personal Care Issues Voluntary Nationwide Recall of Banana Boat Hair & Scalp Sunscreen Due to the Presence of Benzene – UPDATED

January 26, 2023 By The FDA

Hero Highlight

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

Properly Tied Recalls Children’s Lounge Pants Due to Violation of Federal Flammability Standards and Burn Hazard

January 25, 2023 By The CPSC

Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging

January 25, 2023 By The FDA

Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz

January 25, 2023 By The FDA

SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products

January 20, 2023 By The FDA

Lifetime Brands Recalls Hot Chocolate Pots Due to Fire Hazard; Sold Exclusively at Williams-Sonoma

January 18, 2023 By The CPSC

J&J Settles Talc Mesothelioma Settlement

January 15, 2020 By Advice Media

SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products

January 20, 2023 By The FDA

Lifetime Brands Recalls Hot Chocolate Pots Due to Fire Hazard; Sold Exclusively at Williams-Sonoma

January 18, 2023 By The CPSC

Sakar International Recalls Multi-Purpose Helmets Due to Risk of Head Injury

January 18, 2023 By The CPSC

Recall News in Your Inbox

Enter your email address to receive automated recall news updates.

Recent Comments

  • Roger McGowan on ABH NATURE’S PRODUCTS, INC, ABH PHARMA, INC., and STOCKNUTRA.COM, INC. Issues Nationwide Recall of All Lots of Dietary Supplement Products
  • Kathryn Moore on FDA Wants Cancer Warning on Breast Implants
  • BRAD on Huge ATV Recall by Polaris – Sportsman and Scrambler
  • Crystal Anderson on Allergan Voluntarily Recalls BIOCELL® Textured Breast Implants and Tissue Expanders
  • Outsourcing Training on The Modern Marketing of Pain
  • SANDRA Collett on Processed Food Preservative Linked to Autism?
  • Eric Karsh on Health Risks of Roundup Go Well Beyond Cancer

Recent Posts

  • Daiso Issues Allergy Alert on Undeclared Soy in Matsunga Mini Shiruko Sand Biscuits
  • Sovos Brands Intermediate, Inc. Issues Allergy Alert on Undeclared Egg in Rao’s Slow Simmered Soup, Labeled as Chicken & Gnocchi but Containing Vegetable Minestrone
  • Edgewell Personal Care Issues Voluntary Nationwide Recall of Banana Boat Hair & Scalp Sunscreen Due to the Presence of Benzene – UPDATED
  • Joy Joy’s Bakery Issues Allergy Alert on Undeclared Wheat in Ube Spanish Bread, Ube Ensaymada, and Ube Roll
  • ZLINE Expands Recall of Gas Ranges to Include 48-inch Gas Ranges Due to Serious Risk of Injury or Death from Carbon Monoxide Poisoning
  • Properly Tied Recalls Children’s Lounge Pants Due to Violation of Federal Flammability Standards and Burn Hazard
  • Snack Innovations Inc. Conducts Voluntary Recall on a Limited Quantity of Drizzilicious Mini Rice Cakes 4oz & .74oz and Popcorn 3.6oz Products in the U.S. Due to Undeclared Peanut Allergen on Packaging
  • Almondy is Initiating a Recall of a Limited Quantity of Almondy Chocolate Cake with Daim 14.1oz
  • SkinnyDipped® Issues Allergy Alert on Undeclared Peanuts in a Limited Number of SkinnyDipped® Dark Chocolate Nut Products
-- See More Recall News

Disclaimer: The information contained in these topics is not intended nor implied to be a substitute for professional medical or legal advice, it is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.


ATTORNEY ADVERTISING. The information provided on this website is not legal advice. No attorney-client relationship is formed by the use of this site. It is not stated or implied that a lawyer is certified as a specialist in any particular field of law. No results are guaranteed, and prior results do not guarantee a similar outcome. This site is informational, only, not dispositive; it is up to you to decide whether a particular lawyer is right for you. Use of this site is subject to your agreement to these.


Copyright © 2023 Altrumedia · Terms of Service · Log in